Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Abbott Labs (ABT) Pipeline Makes Headlines but 2 Products Are Churning Out Record Results - Cowen
-
Abbott Labs (ABT) PT Raised to $140 at Cowen Ahead of ESC 2021 Where Positive Data is Expected
-
Pre-Open Stock Movers 06/01: (OEG) (CLDR) (AMC) Higher; (ABT) (ZIM) (FFIV) Lower (more...)
-
Abbott Labs (ABT) PT Raised to $140 at Cowen
-
Abbott Labs (ABT) PT Raised to $113 at Cowen Into Q3 Results
-
Libre 3's CE Mark Risk to DexCom (DXCM) 'Sentiment, Not Estimates' - Cowen
-
Buy Weakness in MDx Stocks Following Abbott Test-Related Sell-Off - Cowen
-
Cowen Remains Bullish On Abbott Labs (ABT) Despite A Year Ahead Of Tough Comps
-
FDA Approval for New Abbott Labs (ABT) MitraClip Indication 'Triples' U.S. Patient Population - Cowen
-
Abbott Labs (ABT) PT Raised to $86 at Cowen
-
Abbott Labs (ABT) PT Raised to $72 at Cowen
-
Pre-Open Movers 01/02: (NETE) (WATT) (AKAO) Higher; (WFT) (TSRO) (MLCO) Lower (more...)
-
DexCom (DXCM) PT Lowered to $64 at Cowen
-
Abbott (ABT): The Biggest Beneficiary Of CMS Coverage Changes For MRI - Cowen
-
Abbott Labs (ABT) PT Raised to $55 at Cowen; 'Refining Sales Estimates Ahead of Q2 Results'
-
Cowen Reiterates Outperform Rating and $48 PT on Abbott Labs (ABT) Following Q1 Report; 'Expect Sequentially Improving Sales Growth'
-
Cowen Reiterates Outperform Rating and $48 PT on Abbott Labs (ABT); 'ABT/STJ/ALR Combined Entity Finalized' at $51/Share
-
Streetinsider.com's Hot Lunchtime Reads 8/26: (RAX) (DSS) (KS) (ALR) (MOV)
-
Notable Analyst Rating Changes 2/5: (GS) (ALL) (ABT) Upgraded; (LNKD) (KSS) (LINE) Downgraded
-
Pre-Open Stock Movers 02/01: (ALR) (STR) (TROV) Higher; (GPRO) (TSLA) (D) Lower (more...)
-
Notable Analyst Rating Changes 12/7: (ABT) (NSC) (MCC) Upgraded; (CMG) (BLUE) (ARMH) Downgraded
-
It's Time for Mylan (MYL) to Sell Itself - Cowen
-
Notable Analyst Rating Changes 12/20: (LHO) (FLIR) (AWAY) Upgraded; (NOK) (SD) (GBX) Downgraded
-
Notable Analyst Rating Changes 03/19: (ABT) (PCX) (GPS) Upgraded; (EBAY) (RDC) (S) Downgraded
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Daily State of the Markets 01/18: Has 'That Something' Arrived?